Pes
Published on September 18, 2026
Risk Factors
Exposure to rodents or their fleas (ground squirrels, prairie dogs) in endemic areas (southwestern United States, sub-Saharan Africa, Central Asia); hunters, veterinarians, homeless individuals; laboratory workers handling Y. pestis; bioterrorism exposure
Etiology
Yersinia pestis, a gram-negative coccobacillus with characteristic bipolar "safety pin" staining on Wright-Giemsa or Wayson stain
Presentation
Sudden high fever, rigors, and exquisitely tender regional lymphadenopathy (bubo) after flea bite; rapidly progressive pneumonia with hemoptysis (pneumonic form); fulminant sepsis with purpura and acral gangrene (septicemic form)
Classic Exam
Tender, swollen, erythematous lymph node (bubo), most commonly inguinal; may have overlying skin eschar at inoculation site; DIC-related purpura and digital gangrene in septicemic plague
Diagnostics
Blood or bubo aspirate culture growing Y. pestis; bipolar staining organisms on Gram or Wayson stain; chest radiograph with bilateral alveolar infiltrates in pneumonic form; leukocytosis with left shift, elevated LDH, evidence of DIC
Management
Streptomycin or gentamicin as first-line; doxycycline or ciprofloxacin for milder disease or post-exposure prophylaxis; droplet precautions for pneumonic plague; mandatory public health notification
Keywords
"Painful inguinal bubo," "flea bite," "prairie dog exposure," "safety pin bipolar staining," "Black Death," "hemoptysis with rapidly fatal pneumonia," "rat flea," "Category A bioterrorism agent"
01Pathophysiology
Yersinia pestis is a facultative intracellular gram-negative coccobacillus belonging to the family Enterobacteriaceae. The organism is maintained in a zoonotic cycle involving rodents and their fleas, primarily Xenopsylla cheopis (the Oriental rat flea). Human infection begins when an infected flea regurgitates organisms into the skin during a blood meal. The flea's proventriculus becomes blocked by a biofilm of Y. pestis, forcing the flea to regurgitate bacteria with each feeding attempt, which is why the flea bites repeatedly and transmits the organism so efficiently.
Once inoculated into the skin, Y. pestis is phagocytosed by tissue macrophages but is not killed. Instead, the organism uses a Type III secretion system to inject Yop (Yersinia outer proteins) effectors directly into host immune cells. These Yop proteins disable phagocyte killing mechanisms, block cytokine production, and induce apoptosis of macrophages. This is why the host's initial immune response fails and the bacteria proliferate unchecked.
The organisms travel via lymphatics to the regional lymph node, where they multiply rapidly. This produces the hallmark bubo, an intensely inflamed, necrotic, hemorrhagic lymph node. The bubo's location reflects the site of the flea bite: because flea bites most commonly occur on the lower extremities, the inguinal nodes are the most frequently affected. The extreme tenderness of the bubo is due to hemorrhagic necrosis and acute neutrophilic infiltration within the node.
From the lymph node, bacteria can seed the bloodstream, producing secondary septicemic plague with high-grade bacteremia. Endotoxin (lipopolysaccharide) release triggers a systemic inflammatory response that leads to disseminated intravascular coagulation (DIC), which causes the characteristic purpura and peripheral gangrene that historically gave plague its name, the "Black Death." Hematogenous seeding of the lungs produces secondary pneumonic plague. This is clinically important because pneumonic plague can then be transmitted person-to-person via respiratory droplets, creating the potential for epidemic spread without any flea vector.
Primary pneumonic plague results from direct inhalation of Y. pestis (from another patient or aerosolized bioweapon). It bypasses the lymphatic stage entirely and presents as a fulminant necrotizing pneumonia. The incubation period is extremely short (1 to 3 days), and untreated pneumonic plague is nearly 100% fatal within 24 to 72 hours of symptom onset. This rapid lethality is a direct consequence of unimpeded bacterial proliferation in alveolar spaces, endotoxin-driven alveolar destruction, and overwhelming sepsis.
02Classification and Clinical Manifestation
Bubonic
Frequency
~80-85% of cases
Transmission
Flea bite
Incubation
2 to 6 days
Clinical Features
Sudden fever, chills, headache; exquisitely tender regional lymphadenopathy (bubo), most often inguinal; may have skin eschar at bite site
Mortality (Untreated)
~50-60%
Septicemic (primary)
Frequency
~10-15% of cases
Transmission
Flea bite (no visible bubo develops)
Incubation
2 to 6 days
Clinical Features
High fever, rigors, prostration; GI symptoms (nausea, vomiting, diarrhea, abdominal pain); purpura, ecchymoses, acral gangrene; DIC; multi-organ failure
Mortality (Untreated)
~100%
Pneumonic (primary)
Frequency
~2-5% of natural cases; higher in bioterrorism
Transmission
Respiratory droplet inhalation
Incubation
1 to 3 days
Clinical Features
Sudden onset of fever, dyspnea, productive cough with bloody or watery sputum (hemoptysis); rapidly progressive bilateral pneumonia; ARDS
Mortality (Untreated)
~100%
Pharyngeal
Frequency
Rare
Transmission
Ingestion of contaminated meat or inhalation
Incubation
3 to 7 days
Clinical Features
Pharyngitis, cervical lymphadenopathy, fever
Mortality (Untreated)
Variable
Meningitic
Frequency
Rare (complication)
Transmission
Secondary hematogenous spread
Incubation
Variable
Clinical Features
Headache, nuchal rigidity, altered mental status; occurs after inadequate treatment of bubonic plague
Mortality (Untreated)
High
Form | Frequency | Transmission | Incubation | Clinical Features | Mortality (Untreated) |
|---|---|---|---|---|---|
Bubonic | ~80-85% of cases | Flea bite | 2 to 6 days | Sudden fever, chills, headache; exquisitely tender regional lymphadenopathy (bubo), most often inguinal; may have skin eschar at bite site | ~50-60% |
Septicemic (primary) | ~10-15% of cases | Flea bite (no visible bubo develops) | 2 to 6 days | High fever, rigors, prostration; GI symptoms (nausea, vomiting, diarrhea, abdominal pain); purpura, ecchymoses, acral gangrene; DIC; multi-organ failure | ~100% |
Pneumonic (primary) | ~2-5% of natural cases; higher in bioterrorism | Respiratory droplet inhalation | 1 to 3 days | Sudden onset of fever, dyspnea, productive cough with bloody or watery sputum (hemoptysis); rapidly progressive bilateral pneumonia; ARDS | ~100% |
Pharyngeal | Rare | Ingestion of contaminated meat or inhalation | 3 to 7 days | Pharyngitis, cervical lymphadenopathy, fever | Variable |
Meningitic | Rare (complication) | Secondary hematogenous spread | Variable | Headache, nuchal rigidity, altered mental status; occurs after inadequate treatment of bubonic plague | High |
Note that secondary septicemic and secondary pneumonic plague arise as complications of untreated or inadequately treated bubonic plague, and carry the same dire prognosis as their primary counterparts.
03Diagnostic Workup
Gram stain / Wayson stain / Wright-Giemsa stain of bubo aspirate or blood
Role
Best initial test (rapid, bedside)
Key Findings
Gram-negative coccobacillus with bipolar "safety pin" staining
Blood cultures
Role
Confirmatory; always obtain
Key Findings
Growth of Y. pestis (slow grower, may take 48 hours)
Bubo aspirate culture
Role
Confirmatory for bubonic plague
Key Findings
Growth of Y. pestis; yield is higher than blood culture in bubonic form
Sputum Gram stain and culture
Role
Confirmatory for pneumonic plague
Key Findings
Gram-negative coccobacilli in sputum; culture confirmation
Chest radiograph
Role
Required if pneumonic plague suspected
Key Findings
Bilateral alveolar infiltrates, consolidation; may show rapidly progressive opacities
CBC with differential
Role
Supportive
Key Findings
Leukocytosis with bandemia (left shift)
Coagulation studies (PT, PTT, fibrinogen, D-dimer)
Role
Evaluate for DIC
Key Findings
Prolonged PT/PTT, low fibrinogen, elevated D-dimer, thrombocytopenia
Serology (passive hemagglutination / F1 antigen ELISA)
Role
Retrospective or epidemiologic confirmation
Key Findings
Four-fold rise in antibody titer between acute and convalescent sera; single titer is presumptive
Direct fluorescent antibody (DFA) test
Role
Rapid confirmatory (reference labs)
Key Findings
Detection of F1 capsular antigen in clinical specimens
PCR
Role
Rapid molecular confirmation
Key Findings
Detection of Y. pestis DNA; not universally available
Test | Role | Key Findings |
|---|---|---|
Gram stain / Wayson stain / Wright-Giemsa stain of bubo aspirate or blood | Best initial test (rapid, bedside) | Gram-negative coccobacillus with bipolar "safety pin" staining |
Blood cultures | Confirmatory; always obtain | Growth of Y. pestis (slow grower, may take 48 hours) |
Bubo aspirate culture | Confirmatory for bubonic plague | Growth of Y. pestis; yield is higher than blood culture in bubonic form |
Sputum Gram stain and culture | Confirmatory for pneumonic plague | Gram-negative coccobacilli in sputum; culture confirmation |
Chest radiograph | Required if pneumonic plague suspected | Bilateral alveolar infiltrates, consolidation; may show rapidly progressive opacities |
CBC with differential | Supportive | Leukocytosis with bandemia (left shift) |
Coagulation studies (PT, PTT, fibrinogen, D-dimer) | Evaluate for DIC | Prolonged PT/PTT, low fibrinogen, elevated D-dimer, thrombocytopenia |
Serology (passive hemagglutination / F1 antigen ELISA) | Retrospective or epidemiologic confirmation | Four-fold rise in antibody titer between acute and convalescent sera; single titer is presumptive |
Direct fluorescent antibody (DFA) test | Rapid confirmatory (reference labs) | Detection of F1 capsular antigen in clinical specimens |
PCR | Rapid molecular confirmation | Detection of Y. pestis DNA; not universally available |
The workup begins with clinical suspicion, which is the critical step that students often miss. In a vignette, look for a patient from an endemic area (the rural southwestern United States is the classic exam scenario) or with rodent/flea exposure who presents with fever and a painful inguinal bubo. The best initial diagnostic step is aspiration of the bubo (not incision and drainage, which risks spreading organisms) and performing a Gram stain or Wayson stain of the aspirate. The finding of gram-negative coccobacilli with bipolar staining is highly suggestive and should prompt immediate empiric treatment.
Blood cultures should be drawn before antibiotics are started but must not delay treatment. Culture of Y. pestis from blood, bubo aspirate, or sputum is the most accurate (confirmatory) test. The organism grows on standard media but may require 48 hours, so treatment is always initiated on clinical and stain findings, not culture results.
For pneumonic plague, a chest radiograph will show bilateral infiltrates or consolidation. Sputum should be sent for Gram stain and culture under strict biosafety precautions (BSL-3). Laboratory personnel must be notified when plague is suspected, because routine handling of Y. pestis cultures poses a serious occupational risk.
Serology is not useful acutely. It requires paired sera collected 2 to 4 weeks apart and is used primarily for retrospective or epidemiologic confirmation.
Any suspected case of plague must be immediately reported to public health authorities. This is a nationally notifiable disease and a Category A bioterrorism agent, meaning even a single case triggers an investigation.
04Management and Treatment
Bubonic plague (adults)
Preferred Regimen
Streptomycin 1 g IM every 12 hours OR Gentamicin 5 mg/kg IV/IM once daily
Alternative
Doxycycline 100 mg IV/PO every 12 hours; Ciprofloxacin 400 mg IV every 12 hours
Duration
10 to 14 days
Septicemic plague
Preferred Regimen
Gentamicin 5 mg/kg IV once daily (preferred for IV access) OR Streptomycin 1 g IM every 12 hours
Alternative
Ciprofloxacin 400 mg IV every 12 hours; Chloramphenicol (if meningitis suspected)
Duration
10 to 14 days
Pneumonic plague
Preferred Regimen
Gentamicin 5 mg/kg IV once daily OR Streptomycin 1 g IM every 12 hours
Alternative
Ciprofloxacin 400 mg IV every 12 hours; Doxycycline 100 mg IV every 12 hours
Duration
10 to 14 days
Plague meningitis
Preferred Regimen
Chloramphenicol 25 mg/kg IV loading, then 12.5 mg/kg IV every 6 hours
Alternative
Add to aminoglycoside regimen
Duration
10 to 14 days
Post-exposure prophylaxis
Preferred Regimen
Doxycycline 100 mg PO every 12 hours OR Ciprofloxacin 500 mg PO every 12 hours
Alternative
TMP-SMX in children if needed
Duration
7 days
Pregnant patients
Preferred Regimen
Gentamicin 5 mg/kg IV once daily
Alternative
Ciprofloxacin (if gentamicin unavailable); avoid streptomycin and doxycycline
Duration
10 to 14 days
Children
Preferred Regimen
Gentamicin 2.5 mg/kg IV every 8 hours
Alternative
Doxycycline (if 8 years old); Ciprofloxacin
Duration
10 to 14 days
Clinical Scenario | Preferred Regimen | Alternative | Duration |
|---|---|---|---|
Bubonic plague (adults) | Streptomycin 1 g IM every 12 hours OR Gentamicin 5 mg/kg IV/IM once daily | Doxycycline 100 mg IV/PO every 12 hours; Ciprofloxacin 400 mg IV every 12 hours | 10 to 14 days |
Septicemic plague | Gentamicin 5 mg/kg IV once daily (preferred for IV access) OR Streptomycin 1 g IM every 12 hours | Ciprofloxacin 400 mg IV every 12 hours; Chloramphenicol (if meningitis suspected) | 10 to 14 days |
Pneumonic plague | Gentamicin 5 mg/kg IV once daily OR Streptomycin 1 g IM every 12 hours | Ciprofloxacin 400 mg IV every 12 hours; Doxycycline 100 mg IV every 12 hours | 10 to 14 days |
Plague meningitis | Chloramphenicol 25 mg/kg IV loading, then 12.5 mg/kg IV every 6 hours | Add to aminoglycoside regimen | 10 to 14 days |
Post-exposure prophylaxis | Doxycycline 100 mg PO every 12 hours OR Ciprofloxacin 500 mg PO every 12 hours | TMP-SMX in children if needed | 7 days |
Pregnant patients | Gentamicin 5 mg/kg IV once daily | Ciprofloxacin (if gentamicin unavailable); avoid streptomycin and doxycycline | 10 to 14 days |
Children | Gentamicin 2.5 mg/kg IV every 8 hours | Doxycycline (if 8 years old); Ciprofloxacin | 10 to 14 days |
Acute Stabilization
Treatment of plague is a medical emergency. Antibiotics must be started within 24 hours of symptom onset in pneumonic plague to have any chance of survival. The first step in any suspected plague case is to begin empiric antibiotics immediately after obtaining cultures but without waiting for results.
Streptomycin has historically been the gold standard drug for plague and remains the recommended first-line agent in many guidelines. However, because streptomycin is not widely available in many countries, gentamicin has become the practical first-line aminoglycoside and is considered equally effective. For vignettes, know both, but if asked for the "drug of choice" or "first-line treatment," streptomycin or gentamicin are the expected answers.
Doxycycline and fluoroquinolones (ciprofloxacin, levofloxacin) are acceptable alternatives for less severe bubonic plague or when aminoglycosides are contraindicated. They are also the agents of choice for post-exposure prophylaxis in contacts of pneumonic plague cases.
Chloramphenicol has a narrow but important role: it is the preferred agent when plague meningitis is suspected or confirmed, because aminoglycosides do not cross the blood-brain barrier adequately. On the exam, if a patient with plague develops meningeal signs, the next best step is to add chloramphenicol to the aminoglycoside regimen.
Infection Control
Bubonic plague (without pneumonia) requires standard precautions only. Pneumonic plague requires strict droplet precautions (surgical mask, gown, gloves, eye protection) until the patient has completed at least 48 hours of effective antibiotic therapy and shows clinical improvement. Close contacts of pneumonic plague patients must receive post-exposure prophylaxis for 7 days and undergo active surveillance for fever.
Contraindications and Adjustments
In pregnancy, streptomycin is avoided due to fetal ototoxicity, and doxycycline is contraindicated in pregnancy and in children under 8 due to dental/bone effects (though in a life-threatening situation, the benefit may outweigh the risk). Gentamicin becomes the drug of choice in pregnant patients.
Bubo management is supportive. Fluctuant buboes may be aspirated for diagnostic purposes, but incision and drainage is avoided because it can increase the risk of bacteremic spread.
05Differential Diagnosis and Distractors
Tularemia (Francisella tularensis)
Why It Is Similar
Fever, regional lymphadenopathy, ulcer at inoculation site; also involves animal exposure; also a Category A bioterrorism agent
Key Discriminator
Tularemia nodes are typically less tender and do not suppurate as dramatically; exposure is to rabbits, ticks, or deer flies rather than rodents/fleas; ulceroglandular form has a prominent, well-defined skin ulcer
Cat-scratch disease (Bartonella henselae)
Why It Is Similar
Regional lymphadenopathy following animal contact
Key Discriminator
Subacute onset (weeks, not days); patient is less toxic-appearing; history of cat scratch or bite; nodes are firm, not as exquisitely tender; no DIC or sepsis
Lymphogranuloma venereum (Chlamydia trachomatis L1-L3)
Why It Is Similar
Painful inguinal lymphadenopathy with suppuration ("groove sign")
Key Discriminator
Sexually transmitted; genital ulcer precedes adenopathy; no rodent/flea exposure; no sepsis or hemorrhagic features
Staphylococcal/streptococcal lymphadenitis
Why It Is Similar
Painful, red, swollen lymph node with fever
Key Discriminator
Usually follows a visible skin/soft tissue infection; no systemic toxicity to the degree seen in plague; no bipolar-staining organisms
Anthrax (inhalational)
Why It Is Similar
Bioterrorism differential; rapidly fatal illness with mediastinal widening on chest X-ray
Key Discriminator
Anthrax shows widened mediastinum and hemorrhagic mediastinitis, not alveolar infiltrates; no bubo; exposure to spores (mail, animal hides)
Community-acquired pneumonia
Why It Is Similar
Fever, cough, dyspnea, chest infiltrates (for pneumonic plague differential)
Key Discriminator
Pneumonic plague has an explosive onset (hours, not days), hemoptysis, and rapid clinical deterioration; plague has rodent/flea exposure or contact with a pneumonic plague patient; watery or bloody sputum is characteristic
Chancroid (Haemophilus ducreyi)
Why It Is Similar
Painful inguinal lymphadenopathy
Key Discriminator
Sexually transmitted; painful genital ulcer with undermined edges; no systemic toxicity
Differential | Why It Is Similar | Key Discriminator |
|---|---|---|
Tularemia (Francisella tularensis) | Fever, regional lymphadenopathy, ulcer at inoculation site; also involves animal exposure; also a Category A bioterrorism agent | Tularemia nodes are typically less tender and do not suppurate as dramatically; exposure is to rabbits, ticks, or deer flies rather than rodents/fleas; ulceroglandular form has a prominent, well-defined skin ulcer |
Cat-scratch disease (Bartonella henselae) | Regional lymphadenopathy following animal contact | Subacute onset (weeks, not days); patient is less toxic-appearing; history of cat scratch or bite; nodes are firm, not as exquisitely tender; no DIC or sepsis |
Lymphogranuloma venereum (Chlamydia trachomatis L1-L3) | Painful inguinal lymphadenopathy with suppuration ("groove sign") | Sexually transmitted; genital ulcer precedes adenopathy; no rodent/flea exposure; no sepsis or hemorrhagic features |
Staphylococcal/streptococcal lymphadenitis | Painful, red, swollen lymph node with fever | Usually follows a visible skin/soft tissue infection; no systemic toxicity to the degree seen in plague; no bipolar-staining organisms |
Anthrax (inhalational) | Bioterrorism differential; rapidly fatal illness with mediastinal widening on chest X-ray | Anthrax shows widened mediastinum and hemorrhagic mediastinitis, not alveolar infiltrates; no bubo; exposure to spores (mail, animal hides) |
Community-acquired pneumonia | Fever, cough, dyspnea, chest infiltrates (for pneumonic plague differential) | Pneumonic plague has an explosive onset (hours, not days), hemoptysis, and rapid clinical deterioration; plague has rodent/flea exposure or contact with a pneumonic plague patient; watery or bloody sputum is characteristic |
Chancroid (Haemophilus ducreyi) | Painful inguinal lymphadenopathy | Sexually transmitted; painful genital ulcer with undermined edges; no systemic toxicity |
06Traps and High-Yield Pearls
The most common way students lose points on plague questions is by failing to recognize the clinical context. The vignette will almost always include a geographic clue (southwestern United States, rural area, camping, hiking) and an animal exposure clue (dead rodent, prairie dog colony, flea bites). Students who skip over these epidemiologic details and focus only on the lymphadenopathy will be drawn toward more common diagnoses like staphylococcal abscess or cat-scratch disease. The exam is testing whether you can integrate the exposure history with the acuity and severity of the presentation.
A second common trap involves the pneumonic form in a bioterrorism scenario. When the vignette describes a cluster of patients with rapidly progressive pneumonia and hemoptysis without an obvious community-acquired source, students may fixate on ARDS or atypical pneumonia. The expected answer is to consider pneumonic plague (or inhalational anthrax) and to recognize that the next step includes both empiric antibiotics and immediate public health notification.
Another tested concept is the management of the bubo. The instinct is to incise and drain any fluctuant, painful node, but in plague the correct answer is aspiration for diagnostic purposes, not I&D, because incision risks hematogenous dissemination.
Finally, know the prophylaxis question: close contacts (within 2 meters) of a pneumonic plague patient require doxycycline or ciprofloxacin for 7 days. The exam often tests whether you recognize who qualifies as a close contact and what the correct prophylactic regimen is.
The core competency being tested across all plague questions is pattern recognition of a classic infectious disease presentation combined with decisive, time-sensitive management. The exam rewards students who treat immediately on clinical suspicion and do not wait for culture confirmation, who isolate pneumonic plague patients under droplet precautions, and who notify public health without delay.